Skip to content
10-Q

Quarterly Report

PAR PHARMACEUTICAL COMPANIES, INC.

0000878088-15-000007

← back to feed
Filed
May 11, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · May 11, 2015 100 sh
Capex Q1 2015 · Mar 31, 2015 $8.49M
Capex Q1 2015 · Mar 31, 2014 $13.21M
Operating Cash Flow Q1 2015 · Mar 31, 2015 $100.21M
Operating Cash Flow Q1 2015 · Mar 31, 2014 $89.14M
Long Term Debt Q1 2015 · Mar 31, 2015 $2.32B
Long Term Debt Q1 2015 · Dec 31, 2014 $1.9B
Short Term Debt Q1 2015 · Mar 31, 2015 $18.75M
Short Term Debt Q1 2015 · Dec 31, 2014 $14.5M
Cash And Equivalents Q1 2015 · Mar 31, 2015 $185.88M
Cash And Equivalents Q1 2015 · Dec 31, 2014 $244.44M
Cash And Equivalents Q1 2015 · Mar 31, 2014 $220.56M
Cash And Equivalents Q1 2015 · Dec 31, 2013 $130.08M
Stockholders Equity Q1 2015 · Mar 31, 2015 $66.45M
Stockholders Equity Q1 2015 · Dec 31, 2014 $561.07M
Current Liabilities Q1 2015 · Mar 31, 2015 $235.78M
Current Liabilities Q1 2015 · Dec 31, 2014 $277.8M
Current Assets Q1 2015 · Mar 31, 2015 $520.61M
Current Assets Q1 2015 · Dec 31, 2014 $653.05M
Total Assets Q1 2015 · Mar 31, 2015 $2.88B
Total Assets Q1 2015 · Dec 31, 2014 $3.01B
Sga Expense Q1 2015 · Mar 31, 2015 $56.39M
Sga Expense Q1 2015 · Mar 31, 2014 $50.94M
Rd Expense Q1 2015 · Mar 31, 2015 $26.85M
Rd Expense Q1 2015 · Mar 31, 2014 $34.62M
Net Income Q1 2015 · Mar 31, 2015 $20.29M
Net Income Q1 2015 · Mar 31, 2014 −$39.37M
Operating Income Q1 2015 · Mar 31, 2015 $61.5M
Operating Income Q1 2015 · Mar 31, 2014 −$34.16M
Gross Profit Q1 2015 · Mar 31, 2015 $145.07M
Gross Profit Q1 2015 · Mar 31, 2014 $94.31M
Cost Of Revenue Q1 2015 · Mar 31, 2015 $214.17M
Cost Of Revenue Q1 2015 · Mar 31, 2014 $194.77M
Revenue Q1 2015 · Mar 31, 2015 $359.24M
Revenue Q1 2015 · Mar 31, 2014 $289.08M